Targeted cancer immunotherapy Mimicking physiological trans-presentation of IL-15

被引:3
|
作者
Mueller, Dafne [1 ]
机构
[1] Univ Stuttgart, Inst Zellbiol & Immunol, D-70174 Stuttgart, Germany
关键词
IL-15; IL-15R alpha; antibody fusion protein; targeting; trans-presentation; T-CELLS; INTERLEUKIN-15; TUMORS; NK;
D O I
10.4161/onci.20824
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Under physiological conditions, the trans-presentation of interleukin-15 (IL-15) by the IL-15 receptor alpha on the cell surface allows to confine and tune the IL-15-mediated immune responses. Therefore, targeting strategies that mimic this situation at the tumor sites appear especially promising for anticancer immunotherapy.
引用
收藏
页码:1213 / 1214
页数:2
相关论文
共 50 条
  • [21] IL-15 in the Combination Immunotherapy of Cancer
    Waldmann, Thomas A.
    Dubois, Sigrid
    Miljkovic, Milos D.
    Conlon, Kevin C.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [22] Heterodimeric IL-15 in Cancer Immunotherapy
    Bergamaschi, Cristina
    Stravokefalou, Vasiliki
    Stellas, Dimitris
    Karaliota, Sevasti
    Felber, Barbara K.
    Pavlakis, George N.
    CANCERS, 2021, 13 (04) : 1 - 20
  • [23] Dendritic cell-expressed common gamma-chain recruits IL-15 for trans-presentation at the immunological synapse
    Choudhuri, Kaushik
    Beilin, Chiara
    Bouma, Gerben
    Llodra, Jaime
    Malinova, Dessislava
    Stokes, David
    Springer, Timothy
    Shimaoka, Motomu
    Dustin, Michael
    Thrasher, Adrain
    Burns, Siobhan
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [24] CD8+CD122+ T cell homeostasis is controlled by different levels of IL-15 trans-presentation
    Lee, Gilbert Aaron
    Liao, Nan-Shih
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (03) : 514 - 517
  • [25] Out-sourcing for Trans-presentation: Assessing T Cell Intrinsic and Extrinsic IL-15 Expression with Il15 Gene Reporter Mice
    Park, Joo-Young
    Ligons, Davinna L.
    Park, Jung-Hyun
    IMMUNE NETWORK, 2018, 18 (01)
  • [26] Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8 alpha alpha T cells
    Ma, Lisa J.
    Schluns, Kimberly S.
    FASEB JOURNAL, 2008, 22
  • [27] Rationale for IL-15 superagonists in cancer immunotherapy
    Knudson, Karin M.
    Hodge, James W.
    Schlom, Jeffrey
    Gameiro, Sofia R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (07) : 705 - 709
  • [28] Trans-presentation of IL-15 modulates STAT5 activation and Bcl-6 expression in TH1 cells
    Cooley, Ian D.
    Read, Kaitlin A.
    Oestreich, Kenneth J.
    SCIENTIFIC REPORTS, 2015, 5
  • [29] Trans-presentation of IL-15 modulates STAT5 activation and Bcl-6 expression in TH1 cells
    Ian D. Cooley
    Kaitlin A. Read
    Kenneth J. Oestreich
    Scientific Reports, 5
  • [30] IL-15 signaling in NK cell cancer immunotherapy
    Rautela, Jai
    Huntington, Nicholas D.
    CURRENT OPINION IN IMMUNOLOGY, 2017, 44 : 1 - 6